Nanosized drug formulations under microfluidic continuous flow

被引：32
作者：
Dev, Selvi [1 ]
Iyer, K. Swaminathan [1 ]
Raston, Colin L. [1 ]
机构：
[1] Univ Western Australia, Ctr Strateg Nanofabricat, Sch Biomed Biomol & Chem Sci, Crawley, WA 6009, Australia
来源：
LAB ON A CHIP | 2011年 / 11卷 / 19期
关键词：
MICELLAR NANOCONTAINERS; POSTOPERATIVE PAIN; MELOXICAM; DELIVERY; SYSTEM; OPTIMIZATION; GENE;
D O I：
10.1039/c1lc20666d
中图分类号：
Q5 [生物化学];
学科分类号：
071010 ; 081704 ;
摘要：
We present a simple method involving a rotating tube processor to fabricate ultrafine crystalline drug nanoparticles under microfluidic continuous flow with precise control over particle size, with significantly enhanced dissolution of the drug.
引用
收藏
页码：3214 / 3217
页数：4
相关论文
共 29 条
[1]  
Ahmed Mansoor, 2005, Expert Opin Drug Metab Toxicol, V1, P739, DOI 10.1517/17425255.1.4.739
[2]   Determination of meloxicam in human plasma using a HPLC method with UV detection and its application to a pharmacokinetic study [J].
Bae, Jung-Woo ;
Kim, Mi-Jeong ;
Jang, Choon-Gon ;
Lee, Seok-Yong .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2007, 859 (01) :69-73
[3]   Development of a nanoprecipitation method intended for the entrapment of hydrophilic drugs into nanoparticles [J].
Bilati, U ;
Allémann, E ;
Doelker, E .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2005, 24 (01) :67-75
[4]   Formulation optimization of meloxicam sodium gel using response surface methodology [J].
Chang, Jui-Sheng ;
Huang, Yaw-Bin ;
Hou, Sen-Sen ;
Wang, Ren-Jiunn ;
Wu, Pao-Chu ;
Tsai, Yi-Hung .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2007, 338 (1-2) :48-54
[5]   Enhancing the bioavailability of ABT-963 using solid dispersion containing Pluronic F-68 [J].
Chen, Y ;
Zhang, GGZ ;
Neilly, J ;
Marsh, K ;
Mawhinney, D ;
Sanzgiri, YD .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2004, 286 (1-2) :69-80
[6]   The dawning era of polymer therapeutics [J].
Duncan, R .
NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (05) :347-360
[7]   ANTIINFLAMMATORY, ANALGESIC, ANTIPYRETIC AND RELATED PROPERTIES OF MELOXICAM, A NEW NONSTEROIDAL ANTIINFLAMMATORY AGENT WITH FAVORABLE GASTROINTESTINAL TOLERANCE [J].
ENGELHARDT, G ;
HOMMA, D ;
SCHLEGEL, K ;
UTZMANN, R ;
SCHNITZLER, C .
INFLAMMATION RESEARCH, 1995, 44 (10) :423-433
[8]   Improvement of the encapsulation efficiency of oligonucleotide-containing biodegradable microspheres [J].
Freytag, T ;
Dashevsky, A ;
Tillman, L ;
Hardee, GE ;
Bodmeier, R .
JOURNAL OF CONTROLLED RELEASE, 2000, 69 (01) :197-207
[9]  
GIUNCHEDI P, 1995, STP PHARMA SCI, V5, P276
[10]   Improved absorption of meloxicam via salt formation with ethanolamines [J].
Han, Hyo-Kyung ;
Choi, Hoo-Kyun .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2007, 65 (01) :99-103
123